Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Olfactory transduction | R-HSA-9751605 | map04740 | arachidonyltrifluoromethane | 51039 | drug-path |
Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | sirolimus | 5284616 | drug-path |
Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | sirolimus | 5284616 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | sirolimus | 5284616 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | sirolimus | 5284616 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | sirolimus | 5284616 | drug-path |
Nucleotide excision repair | R-HSA-5696398 | map03420 | sirolimus | 5284616 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | sirolimus | 5284616 | drug-path |
DNA replication | R-HSA-69306 | map03030 | sirolimus | 5284616 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | sirolimus | 5284616 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | sirolimus | 5284616 | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | sirolimus | 5284616 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | sirolimus | 5284616 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | sirolimus | 5284616 | drug-path |
Proteasome | R-HSA-68819 | map03050 | sirolimus | 5284616 | drug-path |
Complement and coagulation cascades | R-HSA-114591 | map04610 | sirolimus | 5284616 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | sirolimus | 5284616 | drug-path |
Taste transduction | R-HSA-162582 | map04742 | sirolimus | 5284616 | drug-path |
Primary immunodeficiency | R-HSA-5601905 | map05340 | sirolimus | 5284616 | drug-path |
Base excision repair | R-HSA-73884 | map03410 | sirolimus | 5284616 | drug-path |